相关实验视频
Updated: May 27, 2025

Induction and Analysis of Epithelial to Mesenchymal Transition
Published on: August 27, 2013
通过AKT/Twist信号通路,MCM3通过表皮细胞-介质细胞过渡促进肝细胞癌的进展
Wei-Guo Tang1, Jin-Feng Feng1, Xian Li2
1Department of Hepatobiliary and Pancreatic Surgery, Minhang Hospital, Fudan University, Shanghai 201199, China; Key laboratory of whole-period monitoring and precise intervention of digestive cancer (SMHC), Minhang Hospital, Fudan University, Shanghai 201199, China.
迷你染色体维护复杂组件3 (MCM3) 通过促进细胞迁移和侵入,驱动肝细胞癌 (HCC) 的进展. MCM3表达是一种预后标记,向它可能提供新的HCC疗法.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 癌症研究 癌症研究
背景情况:
- 肝细胞癌 (HCC) 是癌症死亡的主要原因,复发和转移率高.
- 需要新的预后标志物和治疗策略来管理HCC.
- 微染色体维护复杂组件3 (MCM3) 在HCC中的作用尚不清楚.
研究的目的:
- 为了研究MCM3在肝细胞癌中的表达和功能.
- 探索MCM3在HCC患者的预后意义.
- 阐明 MCM3 影响 HCC 进展的潜在分子机制.
主要方法:
- 在HCC细胞系和患者组织中分析MCM3表达.
- 在体外和体外功能测试以评估MCM3在增殖,迁移,入侵和上皮-介质细胞转换 (EMT) 中的作用.
- 探索参与MCM3介导效应的信号通路,包括AKT和Twist.
主要成果:
- 在HCC细胞系和患者样本中观察到MCM3表达升高.
- 较高的MCM3水平与微血管入侵,晚期和较差的生存率相关.
- 在体外,MCM3促进了HCC细胞的增殖,迁移,入侵和EMT,并在体内通过AKT/Twist途径加速了瘤的生长.
结论:
- 在HCC中,MCM3充当瘤原因子,推动疾病的进展.
- MCM3表达是HCC的有价值的预后指标.
- 向MCM3为肝细胞癌提供了一个潜在的新疗法策略.
更多相关视频
08:50In Vitro Cultivation Techniques for Modeling Liver Organogenesis, Building Assembloids, and Designing Synthetic Tissues using Human Cell Lines
Published on: April 18, 2025
06:54Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells
Published on: October 27, 2020
相关概念视频
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
PI3K/mTOR/AKT Signaling Pathway
Metastasis
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Induced Pluripotent Stem Cells
Somatic...
Abnormal Proliferation
Cadherins in Tissue Organization
Cell Sorting During Development
Cell sorting plays an...